Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Formulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapy.

Hsu SH, Wen CJ, Al-Suwayeh SA, Huang YJ, Fang JY.

Nanomedicine (Lond). 2013 Aug;8(8):1253-69. doi: 10.2217/nnm.12.170. Epub 2013 Feb 5.

PMID:
23384703
2.

Quantiosomes as a multimodal nanocarrier for integrating bioimaging and Carboplatin delivery.

Lin CF, Wen CJ, Aljuffali IA, Huang CL, Fang JY.

Pharm Res. 2014 Oct;31(10):2664-76. doi: 10.1007/s11095-014-1363-x. Epub 2014 Jun 7.

PMID:
24906596
3.
4.

Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.

Su Z, Shi Y, Xiao Y, Sun M, Ping Q, Zong L, Li S, Niu J, Huang A, You W, Chen Y, Chen X, Fei J, Tian J.

Int J Pharm. 2013 Apr 15;447(1-2):281-92. doi: 10.1016/j.ijpharm.2013.01.068. Epub 2013 Feb 7.

PMID:
23396258
5.

Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.

Huang ZR, Hua SC, Yang YL, Fang JY.

Acta Pharmacol Sin. 2008 Sep;29(9):1094-102. doi: 10.1111/j.1745-7254.2008.00829.x.

6.

Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.

Safwat S, Ishak RAH, Hathout RM, Mortada ND.

Drug Dev Ind Pharm. 2017 Jul;43(7):1112-1125. doi: 10.1080/03639045.2017.1293681. Epub 2017 Mar 1.

PMID:
28276784
7.

In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.

Abdelbary G, Haider M.

Pharm Dev Technol. 2013 Sep-Oct;18(5):1159-68. doi: 10.3109/10837450.2011.614251. Epub 2011 Sep 29.

PMID:
21958084
8.

Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.

Su Z, Niu J, Xiao Y, Ping Q, Sun M, Huang A, You W, Sang X, Yuan D.

Mol Pharm. 2011 Oct 3;8(5):1641-51. doi: 10.1021/mp100463n. Epub 2011 Aug 16.

PMID:
21770405
9.

Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.

Nekkanti V, Venkateswarlu V, Ansari KA, Pillai R.

Curr Drug Deliv. 2011 Nov;8(6):661-6.

PMID:
22313161
10.

Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.

Liu M, Chen D, Mukerabigwi JF, Chen S, Zhang Y, Lei S, Luo S, Wen Z, Cao Y, Huang X, He H.

J Drug Target. 2016;24(5):433-40. doi: 10.3109/1061186X.2015.1086358. Epub 2015 Sep 30.

PMID:
26422582
11.

Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles.

Tan YF, Chandrasekharan P, Maity D, Yong CX, Chuang KH, Zhao Y, Wang S, Ding J, Feng SS.

Biomaterials. 2011 Apr;32(11):2969-78. doi: 10.1016/j.biomaterials.2010.12.055. Epub 2011 Jan 22.

PMID:
21257200
12.

Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.

Minelli R, Cavalli R, Ellis L, Pettazzoni P, Trotta F, Ciamporcero E, Barrera G, Fantozzi R, Dianzani C, Pili R.

Eur J Pharm Sci. 2012 Nov 20;47(4):686-94. doi: 10.1016/j.ejps.2012.08.003. Epub 2012 Aug 15.

13.

Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.

Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A.

J Control Release. 2007 Dec 4;124(1-2):28-34. Epub 2007 Aug 30.

PMID:
17928088
14.

Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.

Liu D, Liu Z, Wang L, Zhang C, Zhang N.

Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):262-9. doi: 10.1016/j.colsurfb.2011.02.038. Epub 2011 Mar 8.

PMID:
21435845
15.

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.

Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D, Tian X, Liu Y, Zhang Q.

Int J Biol Macromol. 2012 Apr 1;50(3):523-9. doi: 10.1016/j.ijbiomac.2012.01.024. Epub 2012 Jan 24.

PMID:
22301003
16.

Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Gao W, Xiang B, Meng TT, Liu F, Qi XR.

Biomaterials. 2013 May;34(16):4137-49. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1.

PMID:
23453200
17.

PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.

Luan J, Yang X, Chu L, Xi Y, Zhai G.

J Colloid Interface Sci. 2014 Aug 15;428:49-56. doi: 10.1016/j.jcis.2014.04.036. Epub 2014 Apr 24.

PMID:
24910034
18.

Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody.

Liu D, Liu F, Liu Z, Wang L, Zhang N.

Mol Pharm. 2011 Dec 5;8(6):2291-301. doi: 10.1021/mp200402e. Epub 2011 Oct 26.

PMID:
21923159
19.

Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.

Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.

Eur J Pharm Biopharm. 2012 Jun;81(2):248-56. doi: 10.1016/j.ejpb.2012.03.004. Epub 2012 Mar 14.

PMID:
22446630
20.

Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers.

Chu Y, Li D, Luo YF, He XJ, Jiang MY.

Molecules. 2014 Feb 21;19(2):2445-57. doi: 10.3390/molecules19022445.

Supplemental Content

Support Center